Skip to main content

Johnson & Johnson vs Visa: Founders, CEOs and History

Johnson & Johnson was founded in 1886 by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson and is led by Joaquin Duato. Visa was founded in 1958 by Dee Hock and is led by Ryan McInerney.

Company facts

Johnson & Johnson

Founded
1886
Headquarters
New Brunswick, New Jersey
Current CEO
Joaquin Duato
Employees
140,800

Visa

Founded
1958
Headquarters
San Francisco, California
Current CEO
Ryan McInerney
Employees
34,100

Founders

Johnson & Johnson

  • Robert Wood Johnson

    Robert Wood Johnson (1845-1910) co-founded Johnson & Johnson in 1886 and served as its first president.

  • James Wood Johnson

    James Wood Johnson (1856-1932) co-founded J&J with his brothers in 1886. An engineer by trade, he designed the early manufacturing machinery that allowed the company to mass-produce sterile surgical dressings.

  • Edward Mead Johnson

    Edward Mead Johnson (1852-1934) co-founded J&J in 1886, bringing crucial sales and marketing expertise to the early business.

Johnson & Johnson founders in full

Visa

  • Dee Hock

    Dee Hock (1929-2022) was the founding CEO of National BankAmericard Inc., the bank-owned company that took over the BankAmericard licensing system from Bank of America in 1970 and adopted the Visa name in 1976.

Visa founders in full

CEOs and their tenures

Johnson & Johnson

  1. Ralph Larsen1989–2002

    Former Chairman and Chief Executive Officer

    Larsen's acquisitions, including Neutrogena, Cordis, DePuy, and Centocor, broadened J&J into medical devices and biologics, laying groundwork for today's MedTech segment and immunology franchise.

    Source
  2. William Weldon2002–2012

    Former Chairman and Chief Executive Officer

    Weldon's later years were overshadowed by a wave of consumer product recalls, including Tylenol and Motrin, tied to manufacturing-quality problems.

    Source
  3. Alex Gorsky2012–2022

    Former Chairman and Chief Executive Officer

    Gorsky's tenure set up the 2023 Kenvue separation completed under his successor and saw J&J's single-dose COVID-19 vaccine authorized in 2021. He also oversaw the $30 billion Actelion acquisition in 2017 and the early years of talc litigation.

    Source
  4. Joaquin Duato2022–present

    Chairman and Chief Executive Officer

    Under Duato, J&J's sales reached $94.193 billion in FY2025 with $26.804 billion in net earnings, and the company guides to its first $100 billion year in 2026. He also launched the DePuy Synthes separation and the 2026 talc settlement proposal.

    Source
Johnson & Johnson CEO history in full

Visa

  1. Alfred F. Kelly Jr.2016–2023

    Chief Executive Officer

    Serving as CEO from 2016 to 2023, he heavily modernized the massive legacy network, aggressively integrating fintechs and preparing the network to process highly complex cryptocurrency transactions.

    Source
  2. Ryan McInerney2023–present

    Chief Executive Officer

    McInerney joined Visa in 2013 as president after senior roles at JPMorgan Chase and became chief executive on February 1, 2023, succeeding Alfred F. Kelly Jr.

    Source
Visa CEO history in full

Timeline: Johnson & Johnson and Visa side by side

  1. 1886Johnson & Johnson

    Johnson & Johnson Founded

    Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson found the company in New Brunswick, New Jersey, with 14 employees, to mass-produce sterile surgical dressings after Robert was inspired by antiseptic pioneer Joseph Lister's 1885 warnings about i…

  2. 1920Johnson & Johnson

    Band-Aid Brand Adhesive Bandages Introduced

    J&J introduces the first mass-produced adhesive bandage, sold under the Band-Aid brand starting in 1921; it becomes one of the most recognized consumer-health brands in the world before J&J later spins its consumer division out as Kenvue in 2023.

  3. 1943Johnson & Johnson

    Robert Wood Johnson II Writes 'Our Credo'

    Chairman Robert Wood Johnson II authors 'Our Credo,' a one-page statement ranking the company's responsibilities to customers, employees, communities, and shareholders in that order; it remains J&J's official governing philosophy and was later cited as the bas…

  4. 1944Johnson & Johnson

    J&J Goes Public

    Johnson & Johnson lists publicly, becoming an independent, market-traded company as it expands into a diversified healthcare business under Chairman Robert Wood Johnson II.

  5. 1958Visa

    BankAmericard launched

    Bank of America launched BankAmericard, the direct predecessor to Visa.

  6. 1976Visa

    Visa name adopted

    The network adopted the Visa name to support international acceptance and brand consistency.

  7. 1982Johnson & Johnson

    Tylenol Cyanide Poisonings and Nationwide Recall

    After seven people in the Chicago area die from cyanide-laced Extra-Strength Tylenol capsules, J&J issues a nationwide recall of 31 million bottles within a week -- far beyond what investigators said was necessary -- citing Our Credo's customer-safety priority…

  8. 2008Visa

    Visa IPO

    Visa became a public company, changing the economics from a bank association structure to a shareholder-owned company.

  9. 2012Johnson & Johnson

    Alex Gorsky Becomes CEO

    Gorsky succeeds William Weldon as CEO amid a period of manufacturing-quality recalls, and spends the next decade restoring J&J's operational reputation while expanding the pharmaceutical and MedTech businesses and developing a single-dose COVID-19 vaccine duri…

  10. 2016Visa

    Alfred F. Kelly Jr. becomes CEO

    Alfred F. Kelly Jr. became CEO of Visa in 2016. Chief executive of Visa from December 2016 to January 2023, when Ryan McInerney succeeded him; Kelly then served as executive chairman.

  11. 2020Visa

    Acquired Plaid (abandoned)

    Visa acquired Plaid (abandoned) for $5.3 billion. Visa agreed in January 2020 to buy US data-connectivity fintech Plaid for USD 5.3 billion.

  12. 2022Johnson & Johnson

    Joaquin Duato Becomes CEO

    Duato becomes CEO in January 2022, later adding the chairman title, and begins preparing the separation of J&J's consumer-health business from its medicine and device operations.

  13. 2022Visa

    Tink acquisition

    Visa completed its purchase of Stockholm-based open banking platform Tink in March 2022.

  14. 2023Johnson & Johnson

    Kenvue Separation

    J&J completes the spinoff of its consumer-health business (Band-Aid, Tylenol, Listerine, Neutrogena) as the standalone public company Kenvue, narrowing J&J around its higher-margin Innovative Medicine and MedTech segments.

  15. 2023Visa

    Ryan McInerney becomes CEO

    Ryan McInerney became Visa's CEO after serving as president.

  16. 2025Johnson & Johnson

    FY2025 Sales of $94.193B

    Johnson & Johnson reports $94.193 billion in sales and $26.804 billion in net earnings, split roughly 64% Innovative Medicine and 36% MedTech, both segments growing about 6% year over year.

  17. 2025Johnson & Johnson

    Orthopaedics Separation Announced

    In October 2025 J&J announced plans to separate its orthopaedics business as a standalone company operating as DePuy Synthes, targeting completion in 2027.

  18. 2025Visa

    Revenue reaches $40.0B

    Visa reported $40.0 billion in fiscal 2025 net revenue.

  19. 2026Johnson & Johnson

    Proposed Talc Resolution and Raised Guidance

    J&J raised 2026 sales guidance to about $101.1 billion after Q2 sales of $25.31 billion, and on July 27, 2026 proposed an estimated $5.5 billion resolution of remaining ovarian talc claims.

Acquisitions

Johnson & Johnson

  • Intra-Cellular Therapies2025$14.6B
  • Shockwave Medical2024$13.1B
  • Kenvue separation2023Undisclosed
  • Abiomed2022$16.6B
  • Actelion2017$30B
All Johnson & Johnson acquisitions

Visa

  • Tink2022$2.1B
  • Plaid (abandoned)2020$5.3B
  • Visa Europe2016Undisclosed
All Visa acquisitions

Questions about Johnson & Johnson vs Visa

Who is the CEO of Johnson & Johnson and Visa Inc.?

Johnson & Johnson is led by Joaquin Duato and Visa Inc. is led by Ryan McInerney. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Johnson & Johnson founded vs Visa Inc.?

Johnson & Johnson was founded in 1886 — 72 years before Visa Inc., which was founded in 1958. Johnson & Johnson's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Visa Inc..

How many employees does Johnson & Johnson have compared to Visa Inc.?

Johnson & Johnson employs approximately 140,800 people, while Visa Inc. employs approximately 34,100. Johnson & Johnson has the larger workforce at 140,800 employees, compared to Visa Inc.'s 34,100. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Johnson & Johnson and Visa Inc. headquartered?

Both Johnson & Johnson and Visa Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.

Who founded Johnson & Johnson and Visa Inc.?

Johnson & Johnson was founded by Robert Wood Johnson, James Wood Johnson, Edward Mead Johnson. Visa Inc. was founded by Dee Hock.

Which company has a longer operating history — Johnson & Johnson or Visa Inc.?

Johnson & Johnson has been operating for approximately 140 years, making it the more established of the two companies. Visa Inc. has been in operation for around 68 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Johnson & Johnson vs Visa overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.